Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideya Yamazaki

Showing results (71-80 of 212) with videos related to

Pageof 22
Sort By:
Anticancer Research|December 11, 2013
Analysis of intrafractional organ motion for patients with prostate cancer using soft tissue matching image-guided intensity-modulated radiation therapy by helical tomotherapyKazuki Iwama, Hideya Yamazaki, Takuya Nishimura, et al.
Scientific Reports|January 8, 2022
Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancerHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Journal of Radiation Research|January 25, 2014
Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitisNorihiro Aibe, Hideya Yamazaki, Satoaki Nakamura, et al.
Journal of Radiation Research|December 4, 2010
Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomesNaohiro Kodani, Hideya Yamazaki, Takuji Tsubokura, et al.
Radiation Oncology (London, England)|December 15, 2010
Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or olderHideya Yamazaki, Ken Yoshida, Tadayuki Kotsuma, et al.
Cancer Detection and Prevention|June 6, 2003
Comparative analysis of G2 arrest after irradiation with 75 keV carbon-ion beams and 137Cs gamma-rays in a human lymphoblastoid cell lineSatoko Matsumura, Tatsushi Matsumura, Shuji Ozeki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicityYasuo Yoshioka, Takayuki Nose, Ken Yoshida, et al.
Anticancer Research|September 12, 2013
Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosisKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Scientific Reports|February 22, 2023
Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional studyHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancerNaoya Kakimoto, Takehiro Inoue, Toshihiko Inoue, et al.
Pageof 22

Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Anticancer Research|December 11, 2013
Analysis of intrafractional organ motion for patients with prostate cancer using soft tissue matching image-guided intensity-modulated radiation therapy by helical tomotherapyKazuki Iwama, Hideya Yamazaki, Takuya Nishimura, et al.
Scientific Reports|January 8, 2022
Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancerHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Journal of Radiation Research|January 25, 2014
Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitisNorihiro Aibe, Hideya Yamazaki, Satoaki Nakamura, et al.
Journal of Radiation Research|December 4, 2010
Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomesNaohiro Kodani, Hideya Yamazaki, Takuji Tsubokura, et al.
Radiation Oncology (London, England)|December 15, 2010
Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or olderHideya Yamazaki, Ken Yoshida, Tadayuki Kotsuma, et al.
Cancer Detection and Prevention|June 6, 2003
Comparative analysis of G2 arrest after irradiation with 75 keV carbon-ion beams and 137Cs gamma-rays in a human lymphoblastoid cell lineSatoko Matsumura, Tatsushi Matsumura, Shuji Ozeki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicityYasuo Yoshioka, Takayuki Nose, Ken Yoshida, et al.
Anticancer Research|September 12, 2013
Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosisKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Scientific Reports|February 22, 2023
Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional studyHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancerNaoya Kakimoto, Takehiro Inoue, Toshihiko Inoue, et al.
Pageof 22